The emerging role of PI3K/AKT-mediated epigenetic regulation in cancer.

Saved in:
Bibliographic Details
Title: The emerging role of PI3K/AKT-mediated epigenetic regulation in cancer.
Authors: Spangle JM; Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 44 Binney St, Boston, MA 02115, USA. Electronic address: jennifer_spangle@dfci.harvard.edu., Roberts TM; Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 44 Binney St, Boston, MA 02115, USA., Zhao JJ; Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 44 Binney St, Boston, MA 02115, USA. Electronic address: jean_zhao@dfci.harvard.edu.
Source: Biochimica et biophysica acta. Reviews on cancer [Biochim Biophys Acta Rev Cancer] 2017 Aug; Vol. 1868 (1), pp. 123-131. Date of Electronic Publication: 2017 Mar 14.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9806362 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0304-419X (Print) Linking ISSN: 0304419X NLM ISO Abbreviation: Biochim Biophys Acta Rev Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0304-419X
DOI:10.1016/j.bbcan.2017.03.002